Cargando…

Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study

Background: Serum asialo α1-acid gycoprotein (AsAGP) is a novel biomarker specific to liver fibrosis. Aim: To evaluate the diagnostic efficacy of serum AsAGP levels in classifying the severity of liver fibrosis and differentiating liver cirrhosis (LC) in patients with chronic hepatitis B (CHB) from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yoonseok, Bae, Seryun, Kim, Ji Hoon, Kwak, Minjung, Jeon, So Yeon, Kim, Taehyung, Yim, Sun Young, Lee, Young-Sun, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863335/ https://www.ncbi.nlm.nih.gov/pubmed/36675640 http://dx.doi.org/10.3390/jcm12020712

Ejemplares similares

Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Diagnostic Performance of Serum Asialo α(1)-Acid Glycoprotein Levels to Predict Liver Cirrhosis
por: Lim, Dae Hyun, et al.
Publicado: (2021)

Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis
por: Lee, Han Ah, et al.
Publicado: (2021)

Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression
por: Gim, Jeong-An, et al.
Publicado: (2021)

Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis
por: Lee, Han Ah, et al.
Publicado: (2022)

Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients
por: Kim, Sehwa, et al.
Publicado: (2021)

Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores
por: Kim, Tae Hyung, et al.
Publicado: (2020)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Reversal of liver cirrhosis: current evidence and expectations
por: Jung, Young Kul, et al.
Publicado: (2017)

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
por: Gu, Dae Hoe, et al.
Publicado: (2018)

Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
por: Kim, Tae Hyung, et al.
Publicado: (2023)

Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP
por: Lee, Young-Sun, et al.
Publicado: (2020)

Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
por: Lee, Ji Hun, et al.
Publicado: (2022)

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021)

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome
por: Lee, Han Ah, et al.
Publicado: (2021)

Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease
por: Lee, Young-Sun, et al.
Publicado: (2020)

Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models
por: Kang, Seong Hee, et al.
Publicado: (2022)

Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review
por: Kim, Tae Suk, et al.
Publicado: (2017)

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
por: Jung, Young Kul, et al.
Publicado: (2011)

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
por: Lee, Young-Sun, et al.
Publicado: (2017)

Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis
por: Shin, Seung Kak, et al.
Publicado: (2021)

Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis
por: Lee, Young-Sun, et al.
Publicado: (2021)

Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery
por: Lee, Young-Sun, et al.
Publicado: (2019)

Hepatitis B Viral Surface Mutations in Patients with Adefovir Resistant Chronic Hepatitis B with A181T/V Polymerase Mutations
por: Kim, Jeong Han, et al.
Publicado: (2010)

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach
por: Park, Sang Jung, et al.
Publicado: (2016)

Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
por: Lee, Han Ah, et al.
Publicado: (2016)

Significance of Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
por: Seo, Yeon Seok, et al.
Publicado: (2009)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
por: Yim, Hyung Joon, et al.
Publicado: (2023)

Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis
por: Bae, Sung Hun, et al.
Publicado: (2022)

Evaluation of Treatment Response after Endoscopic Variceal Obturation with Abdominal Computed Tomography
por: Lee, Han Ah, et al.
Publicado: (2020)

Everolimus-induced activation of latent Mycobacterium tuberculosis infection in a patient with metastatic renal cell carcinoma
por: Jeon, So-Yeon, et al.
Publicado: (2017)

Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
por: Lee, Young-Sun, et al.
Publicado: (2018)

The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma
por: Kang, Keunhee, et al.
Publicado: (2015)

Impact of the interval between coronary angiography and off-pump coronary bypass surgery on postoperative renal function
por: Kim, Na-young, et al.
Publicado: (2010)

Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report
por: Jeon, So-Yeon, et al.
Publicado: (2019)

Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014)

Bleeding complications in critically ill patients with liver cirrhosis
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5udelmcgfdlac9kuhlira59tm5